| |
| |
|
| Insider
Information: |
Hyde Joseph R III |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,411,298 |
|
|
Indirect Shares
|
2,672,247 |
|
|
| Direct
Value |
$245,254,219 |
|
|
|
Indirect Value
|
$6,749,827 |
|
|
| Total
Shares |
7,083,545 |
|
|
| Total
Value |
$252,004,046 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fedex Corp |
FDX |
Director |
2009-04-29 |
132,000 |
2008-11-03 |
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director, 10% Owner |
2019-01-02 |
4,207,368 |
2019-01-02 |
2,670,247 |
Premium* |
|
|
Autozone Inc |
AZO |
Director |
2018-01-01 |
71,930 |
2018-01-01 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-01-30 |
4 |
B |
$10.94 |
$422,110 |
D/D |
38,570 |
7,630,127 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-03-10 |
4 |
B |
$8.95 |
$101,289 |
D/D |
11,323 |
7,641,450 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-04-01 |
4 |
A |
$10.58 |
$9,000 |
D/D |
851 |
7,642,301 |
0 |
- |
|
| FDX |
Fedex Corp |
Director |
– • – |
2009-04-29 |
4 |
OE |
$35.89 |
$902,780 |
D/D |
24,000 |
132,000 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-06-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
144,645 |
144,645 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-06-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
258,995 |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-07-01 |
4 |
A |
$9.23 |
$8,250 |
D/D |
894 |
7,708,477 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-10-01 |
4 |
A |
$12.80 |
$9,000 |
D/D |
703 |
7,709,180 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
463,482 |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-11-20 |
4 |
GA |
$0.00 |
$0 |
D/D |
463,482 |
8,172,662 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-01-01 |
4 |
A |
$4.20 |
$10,500 |
D/D |
2,500 |
6,375,162 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-01-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
300,000 |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-01-27 |
4 |
GA |
$0.00 |
$0 |
D/D |
300,000 |
6,675,162 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-04-01 |
4 |
A |
$3.35 |
$9,750 |
D/D |
2,910 |
6,678,072 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-04-16 |
4 |
GA |
$0.00 |
$0 |
D/D |
100,000 |
6,778,072 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-04-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
100,000 |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-05 |
4 |
B |
$3.47 |
$69,400 |
I/I |
20,000 |
735,716 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-06 |
4 |
B |
$3.36 |
$67,200 |
I/I |
20,000 |
755,716 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-07 |
4 |
B |
$3.25 |
$62,355 |
I/I |
19,198 |
774,914 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-10 |
4 |
B |
$3.32 |
$66,440 |
I/I |
20,000 |
794,914 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-11 |
4 |
B |
$3.59 |
$71,820 |
I/I |
20,000 |
814,914 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-12 |
4 |
B |
$3.70 |
$92,525 |
I/I |
25,000 |
839,914 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-17 |
4 |
B |
$3.74 |
$10,452 |
I/I |
2,794 |
845,109 |
2.17 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-27 |
4 |
B |
$2.04 |
$408,000 |
I/I |
200,000 |
1,045,109 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2010-05-28 |
4 |
B |
$2.01 |
$301,500 |
I/I |
150,000 |
1,195,109 |
2.25 |
- |
|
178 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
